(Q83880274)

English

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice

scientific article published on 15 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

author name string

Hou Jing

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lu Yong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Liu Haiyan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ma Yanjun

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Xing Yun

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Zhang Yu

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Li Taiming

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Cao Rongyue

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jin Liang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Wu Jie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Zong Li

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Liu Jingjing

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4102-4109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Role of Inflammation in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Role of heat shock proteins in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Perspectives on mucosal vaccines: is mucosal tolerance a barrier?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

The Mycobacterium leprae hsp65 displays proteolytic activity. Mutagenesis studies indicate that the M. leprae hsp65 proteolytic activity is catalytically related to the HslVU protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Lactococcus lactis as a cell factory for delivery of therapeutic proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Production of human papillomavirus type 16 E7 protein in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Current issues in the treatment of human diseases by mucosal tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Survival of lactococci during passage through mouse digestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Genetic transformation of intact Lactococcus lactis subsp. lactis by high-voltage electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.03.105

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83880274&oldid=2006024024"